117 related articles for article (PubMed ID: 19150938)
1. Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer.
Kioulafa M; Kaklamanis L; Stathopoulos E; Mavroudis D; Georgoulias V; Lianidou ES
Ann Oncol; 2009 Jun; 20(6):1020-5. PubMed ID: 19150938
[TBL] [Abstract][Full Text] [Related]
2. Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer.
Kioulafa M; Balkouranidou I; Sotiropoulou G; Kaklamanis L; Mavroudis D; Georgoulias V; Lianidou ES
Int J Cancer; 2009 Dec; 125(12):2887-92. PubMed ID: 19551853
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Alexopoulou DK; Papadopoulos IN; Scorilas A
Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Sidiropoulos M; Pampalakis G; Sotiropoulou G; Katsaros D; Diamandis EP
Tumour Biol; 2005; 26(6):324-36. PubMed ID: 16254462
[TBL] [Abstract][Full Text] [Related]
5. Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers.
Panagopoulou M; Karaglani M; Balgkouranidou I; Biziota E; Koukaki T; Karamitrousis E; Nena E; Tsamardinos I; Kolios G; Lianidou E; Kakolyris S; Chatzaki E
Oncogene; 2019 May; 38(18):3387-3401. PubMed ID: 30643192
[TBL] [Abstract][Full Text] [Related]
6. Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer.
Olkhov-Mitsel E; Van der Kwast T; Kron KJ; Ozcelik H; Briollais L; Massey C; Recker F; Kwiatkowski M; Fleshner NE; Diamandis EP; Zlotta AR; Bapat B
Epigenetics; 2012 Sep; 7(9):1037-45. PubMed ID: 22874102
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer.
Jiao X; Lu HJ; Zhai MM; Tan ZJ; Zhi HN; Liu XM; Liu CH; Zhang DP
World J Gastroenterol; 2013 Dec; 19(48):9425-31. PubMed ID: 24409072
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of RASSF1A promoter methylation in operable breast cancer.
Kioulafa M; Kaklamanis L; Mavroudis D; Georgoulias V; Lianidou ES
Clin Biochem; 2009 Jul; 42(10-11):970-5. PubMed ID: 19374895
[TBL] [Abstract][Full Text] [Related]
9. KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study.
El Sherbini MA; Mansour AA; Sallam MM; Shaban EA; Shehab ElDin ZA; El-Shalakany AH
J Ovarian Res; 2018 Apr; 11(1):32. PubMed ID: 29690914
[TBL] [Abstract][Full Text] [Related]
10. Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer.
Zhang Y; Song H; Miao Y; Wang R; Chen L
Cancer Sci; 2010 Apr; 101(4):934-40. PubMed ID: 20180809
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Petraki C; Youssef YM; Dubinski W; Lichner Z; Scorilas A; Pasic MD; Komborozos V; Khalil B; Streutker C; Diamandis EP; Yousef GM
Tumour Biol; 2012 Aug; 33(4):1209-14. PubMed ID: 22437349
[TBL] [Abstract][Full Text] [Related]
13. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
14. Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival.
Batra J; Tan OL; O'Mara T; Zammit R; Nagle CM; Clements JA; Kedda MA; Spurdle AB
Int J Gynecol Cancer; 2010 May; 20(4):529-36. PubMed ID: 20686372
[TBL] [Abstract][Full Text] [Related]
15. Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers.
Bharaj BB; Luo LY; Jung K; Stephan C; Diamandis EP
Prostate; 2002 Apr; 51(1):35-41. PubMed ID: 11920956
[TBL] [Abstract][Full Text] [Related]
16. Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer.
Yousef GM; Scorilas A; Kyriakopoulou LG; Rendl L; Diamandis M; Ponzone R; Biglia N; Giai M; Roagna R; Sismondi P; Diamandis EP
Clin Chem; 2002 Aug; 48(8):1241-50. PubMed ID: 12142380
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
Shvartsman HS; Lu KH; Lee J; Lillie J; Deavers MT; Clifford S; Wolf JK; Mills GB; Bast RC; Gershenson DM; Schmandt R
Gynecol Oncol; 2003 Jul; 90(1):44-50. PubMed ID: 12821340
[TBL] [Abstract][Full Text] [Related]
18. Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.
Yousef GM; White NM; Michael IP; Cho JC; Robb JD; Kurlender L; Khan S; Diamandis EP
Tumour Biol; 2005; 26(5):227-35. PubMed ID: 16103744
[TBL] [Abstract][Full Text] [Related]
19. CST6 promoter methylation in circulating cell-free DNA of breast cancer patients.
Chimonidou M; Tzitzira A; Strati A; Sotiropoulou G; Sfikas C; Malamos N; Georgoulias V; Lianidou E
Clin Biochem; 2013 Feb; 46(3):235-40. PubMed ID: 23006792
[TBL] [Abstract][Full Text] [Related]
20. KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation.
Kato K; Noda T; Kobayashi S; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Takahashi H; Uemura M; Asaoka T; Shimizu J; Doki Y; Eguchi H
Cancer Sci; 2024 May; 115(5):1520-1535. PubMed ID: 38475666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]